Stifel Nicolaus Starts Marinus Pharmaceuticals (MRNS) at Buy
Tweet
Share
E-mailGet Alerts MRNS Hot Sheet
Price: $1.48 +0.68%
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 2
Rating Summary:
11 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 2
Join SI Premium – FREE
Stifel Nicolaus initiated coverage on Marinus Pharmaceuticals (NASDAQ: MRNS) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on Marinus Pharmaceuticals click here. For more ratings news on Marinus Pharmaceuticals click here.
Shares of Marinus Pharmaceuticals closed at $8.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loop Capital Starts MongoDB (MDB) at Buy, '2H Ramp Ahead'
- BofA Securities Reinstates Petronet LNG Ltd. (PLNG:IN) at Neutral
- JPMorgan Downgrades MP Materials (MP) to Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
